Stocks & Investing
Stocks and Investing
Stocks and Investing
Thu, February 10, 2011
Wed, February 9, 2011 BSX, INTU, BAX, HCBK, TLAB, GS Expected to Trade Lower After Bearish Patterns Develop
February 9, 2011 / M2 PRESSWIRE / BUYINS.NET / http://www.squeezetrigger.com is monitoring top technical trading patterns and these stocks are the most likely to trade Lower in the coming weeks. BOSTON SCIENTIFIC CORP (NYSE:BSX), INTUIT INC (NASDAQ:INTU), BAXTER INTERNATIONAL INC (NYSE:BAX), HUDSON CITY BANCORP INC (NASDAQ:HCBK), TELLABS INC (NASDAQ:TLAB), GOLDMAN SACHS GROUP INC (NYSE:GS) are all expected to go Lower as Sell signals have been generated by top technical trading patterns. We monitor these patterns: Support Break, Support Reversal, Breakaway Gap, Measured Gap, Exhaustion Gap, Resistance Break, Resistance Reversal, Saucer Reversal, Volume Climax, Volume Trend, Fibonacci Reversal, Consolidation Breaks, Trend Line Break,Trend Line Reversal, Candles, Golden Crosses, Death Crosses and more. The chart below displays the stocks expected to go Lower along with pattern, strategy and strength ratings.
Symbol Company Strategy Pattern Name Strength
BSX BOSTON SCIENTIFIC CORP Breakout (Stocks) DO (+1) Flag, Falling Continuation 2
INTU INTUIT INC Breakout (Stocks) DO Support Reversal(1) 3
BAX BAXTER INTERNATIONAL INC Breakout (Stocks) DO Trend Line Reversal(4) 2
HCBK HUDSON CITY BANCORP INC Trending (Stocks) DO Saucer 3
TLAB TELLABS INC Trending (Stocks) DO Trend Line Break(3) 3
GS GOLDMAN SACHS GROUP INC Breakout (Stocks) DO Wedge, Rising 3
Chart Pattern Recognition is based on a 20-year patterns database. This database is used to determine pattern strength for patterns as they appear. There is no optimization and the pattern signals never change. For each pattern variation, we record accuracy and profitability statistics in a patterns database. From this information, we are able to define strength ratings from 1 to 5. The '1' rating shows ALL patterns while a '5' rating shows the best patterns according to profitability. Each pattern has its own strength rating factors. The result is an automatic ranking system that allows us to only show the BEST patterns. You can see that, at Strength 5, virtually all the patterns are profitable. The pattern strength rating system separates the most profitable patterns. The specific technology used to make these predictions is available for a low monthly fee at: http://www.squeezetrigger.com/services/sw/ot.php
BOSTON SCIENTIFIC CORP (NYSE:BSX) - Boston Scientific Corporation develops, manufactures, and markets medical devices used in various interventional medical specialties worldwide. It offers cardiac rhythm management products, which monitor the heart and deliver electricity to treat cardiac abnormalities; and RF generators, intracardiac ultrasound and steerable ablation catheters, and diagnostic catheters for the diagnosis and treatment of cardiac arrhythmias. The company also provides interventional cardiology products, such as coronary stent systems, coronary revascularization products to treat patients with atherosclerosis and intraluminal catheter-directed ultrasound imaging catheters and systems; vascular access products, balloon catheters, stents and peripheral vascular catheters, wires, and accessories, as well as products for peripheral embolization procedures; and biliary stents, drainage catheters, and micro-puncture sets to treat, diagnose, and ease various forms of benign and malignant tumors. In addition, it offers coated and uncoated detachable coils, micro-delivery stents, micro-guidewires, micro-catheters, guiding catheters, and embolics to neuro-interventional radiologists and neurosurgeons to treat diseases of the neurovascular system; and endoscopy and interventional bronchoscopy products to diagnose and treat various digestive diseases, as well as pulmonary disease systems within the airway and lungs. Further, the company provides urology/womens health products to treat patients with urinary stone disease, benign prostatic hyperplasia, stress urinary incontinence, pelvic organ prolapse, and excessive uterine bleeding; and spinal cord stimulation system for the management of chronic intractable pain of the trunk and/or limbs. Boston Scientific Corporation markets its products through direct sales force, and a network of distributors and dealers. The company was founded in 1979 and is headquartered in Natick, Massachusetts with additional offices in Tokyo, Japan and Paris, France.
INTUIT INC (NASDAQ:INTU) - Intuit Inc. provides business and financial management solutions for small and medium sized businesses, consumers, accounting professionals, and financial institutions in the United States, Canada, and the United Kingdom. The company offers QuickBooks financial and business management software and services, technical support, financial supplies, and Web site design and hosting services for small and medium-sized businesses; and small business payroll products and services, as well as merchant services comprising credit and debit card processing, electronic check conversion, and automated clearing house services. It also provides TurboTax income tax preparation products and services for consumers and small business owners; Lacerte and ProSeries professional tax products and services; and QuickBooks Premier Accountant Edition and the QuickBooks ProAdvisor Program for accounting professionals. In addition, the company offers outsourced online banking services for banks and credit unions, as well as Quicken personal finance products and services. Intuit Inc. was founded in 1983 and is headquartered in Mountain View, California.
BAXTER INTERNATIONAL INC (NYSE:BAX) - Baxter International Inc., through its subsidiaries, develops, manufactures, and markets products for people with hemophilia, immune disorders, infectious diseases, kidney disease, trauma, and other chronic and acute medical conditions. It operates in three segments: BioScience, Medication Delivery, and Renal. The BioScience segment processes recombinant and plasma-based proteins to treat hemophilia and other bleeding disorders; plasma-based therapies to treat immune deficiencies, alpha 1-antitrypsin deficiency, burns and shock, and other chronic and acute blood-related conditions; products for regenerative medicine, such as biosurgery products; and vaccines. The Medication Delivery segment manufactures intravenous solutions and administration sets; premixed drugs and drug-reconstitution systems; pre-filled vials and syringes for injectable drugs; intravenous nutrition products; infusion pumps; and inhalation anesthetics. It also offers products and services related to pharmacy compounding, drug formulation, and packaging technologies. The Renal segment provides products to treat end-stage renal disease or irreversible kidney failure. It manufactures solutions and other products for peritoneal dialysis, a home-based therapy; and distributes product for hemodialysis, which is conducted in a hospital or clinic. It markets its products to hospitals, kidney dialysis centers, nursing homes, rehabilitation centers, doctors offices, clinical and medical research laboratories, and patients at home under physician supervision. The company was founded in 1931 and is based in Deerfield, Illinois.
HUDSON CITY BANCORP INC (NASDAQ:HCBK) - Hudson City Bancorp, Inc. operates as the bank holding company for Hudson City Savings Bank that provides a range of retail banking services. It offers a range of deposit accounts, including passbook and statement savings accounts, interest-bearing transaction accounts, checking accounts, money market accounts, and time deposits, as well as IRA accounts and qualified retirement plans. The companys loan portfolio primarily comprises one-to four-family first mortgage loans for residential properties; multi-family and commercial mortgage loans; construction loans; and consumer loans, such as fixed-rate second mortgage loans and home equity credit line loans, as well as collateralized passbook loans, overdraft protection loans, automobile loans, and secured and unsecured commercial lines of credit. As of December 31, 2009, it operated 95 branches located in 17 counties throughout the State of New Jersey; 10 branch offices in Westchester County, 9 branch offices in Suffolk County, 1 branch office each in Putnam and Rockland Counties, and 6 branch offices in Richmond County; and 9 branch offices in Fairfield County, Connecticut. The company was founded in 1868 and is based in Paramus, New Jersey.
TELLABS INC (NASDAQ:TLAB) - Tellabs, Inc. designs, develops, and supports telecommunications networking products for communications service providers worldwide. Its products and services enable customers to deliver wireline and wireless voice, data, and video services to business and residential customers. The company operates through three segments: Broadband, Transport, and Services. The Broadband segment provides access products that enable service providers to deliver bundled voice, video, and high-speed Internet/data services over copper or fiber networks; managed access transport products, which deliver wireless and business services primarily outside of the United States; and data products, including packet-switched products that enable wireline and wireless carriers to deliver business services and next-generation mobile voice and Internet services. The Transport segment enables service providers to transport services and manage bandwidth; and wireline and wireless providers to support wireless and business services for enterprises, as well as provides triple-play voice, video, and data services. The Services segment includes deployment, support, training, systems integration, and network design/consulting services. These services support various phases of the network, such as planning, building, and operating. The company sells its products and services through its direct sales organization, value-added resellers, distributors, and public and private network providers. Its customers include communication services providers, including local exchange carriers; wireline and wireless service providers; multiple system operators; competitive service providers; distributors; original equipment manufacturers; system integrators; and government agencies. The company was founded in 1974 and is headquartered in Naperville, Illinois.
GOLDMAN SACHS GROUP INC (NYSE:GS) - The Goldman Sachs Group, Inc., together with its subsidiaries, provides investment banking, securities, and investment management services to corporations, financial institutions, governments, and high-net-worth individuals worldwide. Its Investment Banking segment offers financial advisory services, including advisory assignments with respect to mergers and acquisitions, divestitures, corporate defense activities, restructurings, and spin-offs; and underwriting services, such as equity underwriting and debt underwriting. The company s Trading and Principal Investments segment engages in market making in, trading of, and investing in commodities and commodity derivatives, including power generation and related activities; credit products, such as credit derivatives, investment-grade corporate securities, high-yield securities, bank and secured loans, municipal securities, emerging market and distressed debt, public and private equity securities, and real estate; currencies and currency derivatives; interest rate products consisting of interest rate derivatives and global government securities; money market instruments, including matched book positions; and mortgage-related securities and loan products, and other asset-backed instruments. This segment also provides equity securities and derivatives; equities and options exchange-based market-making services; securities, futures, and options clearing services; and insurance services, as well as involves in principal investments activities. The company s Asset Management and Securities Services segment offers asset management services comprising investment advisory services, financial planning, and investment products; management of merchant banking funds; and securities services, such as prime brokerage, financing services, and securities lending. The Goldman Sachs Group also provides global investment research services. The company was founded in 1869 and is headquartered in New York, New York.
About BUYINS.NET
BUYINS.NET, www.buyins.net , monitors trading in all US stocks in real time and maintains massive databases of short sale and naked short sale time and sales data, short squeeze SqueezeTrigger prices, market maker price movements, shareholder data, statistical data on earnings, sector correlation, seasonality, hedge fund trading strategies, comparable valuations. Reports include:
REGULATORY & COMPLIANCE NEWS
Friction Factor -- market maker surveillance system tracking Level II market makers in all stocks to determine Price Friction and compliance with new "Fair Market Making Requirements"
RegSHO Naked Shorts -- tracks EVERY failure to deliver in all US stocks and tracks all Threshold Security Lists daily for which stocks have naked shorts that are not in compliance with Regulation SHO
INVESTMENTS & TRADING
SqueezeTrigger -- 29 billion cell database tracks EVERY short sale (not just total short interest) in all US stocks and calculates volume weighted price that a short squeeze will begin in each stock.
Earnings Edge -- predicts probability, price move and length of move before and after all US stock earnings reports.
Seasonality -- predicts probability, price move and length of move based on exact time of year for all US stocks.
Group Trader -- tracks sector rotation and stock correlation to its sector and predicts future moves in ALL sectors and industry groups.
Pattern Scan -- automates tracking of every technical pattern and predicts time and size of move in all stocks.
GATS (Global Automated Trading System) -- tracks all known trading strategies and qualifies and quantifies which are working best in real time.
DISCLAIMER:
BUYINS.NET is not a registered investment advisor and nothing contained in any materials should be construed as a recommendation to buy or sell any securities. BUYINS.NET has not been compensated by any of the above mentioned companies. Past performance is not indicative of future results. Please visit our web site, www.buyins.net , for complete risks and disclosures.
Contact:
BUYINS.NET Thomas Ronk 800-715-9999 tom@buyins.net www.buyins.net
- WOPRAI
- support@woprai.com